PTHrP on normal osteoblast differentiation and function
PTHrP on normal osteoblast differentiation and function
批准号:
7128091
负责人:
RAMIRO Eliseo TORIBIO
金额:
$12.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2009-06-30
关键词:
adipocytesapoptosisbone marrowcell differentiationcell linecell proliferationconfocal scanning microscopyconnective tissue cellsflow cytometrygene deletion mutationgene targetinggenetically modified animalshistochemistry /cytochemistrylaboratory mouseosteoblastsparathyroid hormone related proteinparathyroid hormonespolymerase chain reactionradiographyterminal nick end labelingtissue /cell culturewestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Ramiro Toribio, DVM, PhD intends to become an independent scientist studying endocrine hormones and their role in skeletal biology and pathology in order to support a career in academia and biomedical research. Dr. Ramiro Toribio completed a PhD in calcium regulation in 2001, is board-certified by the American College of Veterinary Internal Medicine (1999), and in 2001 joined the laboratory of Dr. Thomas Rosol in a postdoctoral position. Dr. Toribio is currently an Assistant Professor in the Department of Veterinary Biosciences, the Ohio State University. His research goals are to investigate the role of parathyroid hormone-related protein (PTHrP) on the commitment of bone marrow stromal cells (BMSCs) to the osteoblastic lineage and on osteoblast function. This concept is relevant to medicine and will have clinical applications because decreased bone mass (osteoporosis) and increased bone fragility are conditions that affect millions of Americans. This award will address important biomedical questions with regard to PTHrP and skeletal biology and it will provide Dr. Toribio with the skills necessary to become an independent investigator. Research: PTHrP was initially identified as a factor responsible for humoral hypercalcemia of malignancy (HHM). It is now recognized that PTHrP is an endocrine, paracrine, and autocrine factor with multiple physiological functions. PTHrP has been shown to exert parathyroid hormone-like actions in bone and kidney by binding to the PTH-1 receptor (PTH1R). Deletion of the PTHrP gene is lethal and results in abnormal skeletal development. Recent studies have also shown that some of the effects of PTHrP on cell function are mediated by a nuclear localization signal. Since there is limited information on the role of PTHrP on osteoblast function and our laboratory has been dedicated to study important aspects of PTHrP and bone biology, the overall hypothesis to be tested is that PTHrP is important in the commitment of BMSCs to the osteoblastic lineage and for osteoblast function. To accomplish this goal a series of studies will be performed. Aim 1 will Investigate the role of PTHrP on osteoblast differentiation and function by using BMSCs and osteoblasts from PTHrP and PTH1R knock-out mice as well as by using osteogenic and adipocytic cell lines. Aim 2 will use novel animal models to study the function of PTHrP on BMSC and osteoblast function. PTHrP gene deletion and overexpression in a cell-specific manner will provide relevant information on the role of PTHrP in bone development. Aim 3 will investigate the role of the nuclear localization signal of PTHrP on BMSC and osteoblast function. We have made considerable progress to develop genetically-engineered mice for our future studies (see preliminary data). Results from these experiments will contribute to a better understanding on the role of PTHrP in bone physiology and pathophysiology, and in the creation of new agents to treat bone disease. Environment: The Department of Veterinary Biosciences is a successful unit with extramurally funded researchers in the areas of endocrinology, immunology, virology, molecular biology, and biochemistry. Dr. Thomas Rosol's laboratory will provide an excellent environment for developing the skills necessary to become a successful independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SMALL LAB ANIMAL IMAGING: PROSTATE CANCER, BREAST CANCER
-
批准号:7334989
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2006
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
SMALL LAB ANIMAL IMAGING: BONE DISEASES, OSTEOPOROSIS
-
批准号:7334990
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2006
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
SMALL LAB ANIMAL IMAGING: LEUKEMIA, LUNG CANCER
-
批准号:7334992
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2006
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
Small Laboratory Animal Imaging: High Resolution Microcomputed Tomography System
-
批准号:7047441
-
项目类别:
-
资助金额:$45.78万
-
财政年份:2006
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
SMALL LAB ANIMAL IMAGING: GENE THERAPY, GENETICS
-
批准号:7334991
-
项目类别:
-
资助金额:$13.73万
-
财政年份:2006
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
PTHrP on normal osteoblast differentiation and function
-
批准号:7456364
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
PTHrP on normal osteoblast differentiation and function
-
批准号:6805207
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
PTHrP on normal osteoblast differentiation and function
-
批准号:6933934
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
PTHrP on normal osteoblast differentiation and function
-
批准号:7250856
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
PTHrP on normal osteoblast differentiation and function
-
批准号:6718794
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:RAMIRO Eliseo TORIBIO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: